The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
The company also reported significant progress toward its internally defined Sustainable Development Goals
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Subscribe To Our Newsletter & Stay Updated
